University of Iowa Hospitals and Clinics
Research Study: Volunteers ages 40 and over with COPD (Chronic ObstructivePulmonary Disease) are invited to participate in a University of Iowa study investigating the effect of Roflumilast on exacerbation rates compared with a placebo. The study will involve multiple visits over the next year. Compensation for time and travel expenses is available for those individuals who qualify for the study. For more information pleasecall Kim Sprenger at 319-353-8862 or by e-mail at email@example.com.
Kim Sprenger, RN BS
We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.